[·= ] 2/3. FDA 5033(66%). (GWAS), GWAS ··. (CKD) NR3C2 (Kerendia, finerenone). GWAS NR3C2(intronic) CKD, NR3C2 CKD. IFNAR1 (SLE) (Saphnelo, anifrolumab-fnia). IFNAR1SLE , IFNAR1TYK2SLE. … [+101 chars]
2600 . . . . 7 18 2605 , . 252 23/30 . , , 1 71( , , ) . 20 . 5 (44.1%), 18~49(39.7%), 6~18(11.8%), 50 (4.4%) . . , , , , . · . , , , , . . . , . , , , , .
. , . . . 50 10 2 . · . 2 3 , 2 . 1 15%, 2 25%, 5 45% . 1 50% . . . , . . , . . , . . (BMI 18.5 ) , , , . , D . . 800, 1000, 1500 . 500 . , 300 , . D 800IU . 10~ 3 3, 30 D D .
.[= ] . . . (1 1.5g 3g ) (heart failure with preserved ejection fraction) . . . 50 1713 2 . 0 ( ), 1 ( tsp), 2 (¼ tsp), 3 (½+ tsp) . 3 . 1 , . 2 , . (816) 0. (56%), (81%) . 0 , . , 2 . . , .… [+199 chars]
345 3300 . 345 120 . (DHF) , . 2 , , , . 1096 1054(25 ) . . , 19 5 (2016~2020) 26 330 . 2021 23.4 3300 , 1300 15 . 345 , 120 . . 100% 1 , · 2 .
[= ] . ' (Frontiers in Aging Neuroscience)' . , , , . '' . . . , . . . (CDC) , 30 47% 65 70% . . , ' (F. nucleatum)' . F. , , . , , F. . . F. , . , F. . , F. . . , . (hanjh3438@mdtod… [+17 chars]
. [=sdecoret/] . . . . 2021 6 1 11 27, 2021 12 20 2022 1 17 6 2002 . . . . . , 6.87. , , , . , , . , . BA.1 BA.4 BA.5 . BA.2 BA.1 . . , . , . pomy80@kormedi.com ' ' (https://kormedi… [+8 chars]
